BBV Review

Advertisement

The challenge of managing co-infections

In recent years we have learnt more about the epidemiology of BBV and their co-infections. New treatment regimes have been introduced which have made us aware of the risks of drug to drug interactions.This will be important as new therapeutic agents are developed for use in co-infected patients.

Twitter Updates

BBV Review RT @HenryEChang: Sustainable Development Goals for HBV elimination in South Africa: challenges, progress & the road ahead→https://t.co/TCu…
Wednesday, 22 May 2019 09:04
BBV Review RT @grahamscooke: Two helpful pieces on HCV reinfection from @GregDore2 @ProfJohnDillon at a time when we're trying to get access to retrea…
Sunday, 05 May 2019 13:34
BBV Review RT @HenryEChang: Biological basis for functional cure of chronic hepatitis B→https://t.co/vGzHbrJkbs via Drs. MG Martinez, Barbara Testoni…
Sunday, 05 May 2019 13:33
BBV Review RT @HenryEChang: Prevalence, incidence, & outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review & meta-anal…
Sunday, 05 May 2019 13:31

For accurate and independent information on blood borne viruses, subscribe to our free newsletter.